Corcept Therapeutics, Inc. (CORT)
38.34
-2.49
(-6.10%)
USD |
NASDAQ |
Feb 12, 16:00
38.34
0.00 (0.00%)
After-Hours: 20:00
Corcept Therapeutics Cash from Investing (Quarterly) : 14.64M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Axsome Therapeutics, Inc. | -0.058M |
| United Therapeutics Corp. | 140.90M |
| Harrow, Inc. | -0.225M |
| Ultragenyx Pharmaceutical, Inc. | 117.18M |
| Amneal Pharmaceuticals, Inc. | -22.46M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 54.48M |
| Cash from Financing (Quarterly) | -46.41M |
| Free Cash Flow | 162.57M |
| Free Cash Flow Per Share (Quarterly) | 0.4561 |
| Free Cash Flow to Equity (Quarterly) | 54.73M |
| Free Cash Flow to Firm (Quarterly) | 54.48M |
| Free Cash Flow Yield | 3.55% |